Start
Completion

Effects of Psilocybin in Concussion Headache

RecruitingRegisteredCTG

Double-blind crossover trial (n=12) investigating repeated oral psilocybin (two sessions; low 0.0143 mg/kg or 1 mg and high 0.143 mg/kg or 10 mg) versus placebo for post-traumatic headache.

Details

This randomised, double-blind, crossover study evaluates oral psilocybin (low and high dose) versus placebo in participants with post-traumatic headache over two test days separated by approximately 14 days.

Participants maintain a headache diary before, during and after treatments to record frequency, intensity and associated symptoms; blood samples are collected to measure inflammatory peptides.

Topics:Headache Disorders (Cluster & Migraine)

Registry

Registry linkNCT03806985